Search research articles
Contact Us
Filters
Showing results (41-50 of 118) with videos related to
Page
of 12
Sort By:
Clinical Chemistry and Laboratory Medicine
|
September 20, 2011
The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses
Miriam Lenhard, Petra Stieber, Linda Hertlein, et al.
Virchows Archiv : an International Journal of Pathology
|
February 9, 2019
Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma
Elisa Schmoeckel, Sophie Hofmann, Daniel Fromberger, et al.
International Journal of Molecular Sciences
|
June 20, 2019
Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients
Eileen Deuster, Doris Mayr, Anna Hester, et al.
Zentralblatt Fur Chirurgie
|
September 18, 2025
[The Free Functional Latissimus dorsi Flap for the Reconstruction of Complex Abdominal Wall Defects: Anatomy, Technique and Approach for Interdisciplinary Treatment]
Sinan Mert, Benedikt Fuchs, Alexander Burges, et al.
Brachytherapy
|
June 27, 2018
Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results
Franziska Walter, Cornelius Maihöfer, Lars Schüttrumpf, et al.
British Journal of Clinical Pharmacology
|
June 23, 2010
Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients
Peter Ruf, Michael Kluge, Michael Jäger, et al.
Clinical Chemistry
|
March 4, 2008
A new ELISA for use in a 3-ELISA system to assess concentrations of VEGF splice variants and VEGF(110) in ovarian cancer tumors
Johnny Gutierrez, Gottfried E Konecny, Kyu Hong, et al.
Cancers
|
January 25, 2025
Necroptosis-Related Gene Signature Predicts Prognosis in Patients with Advanced Ovarian Cancer
Mingjun Zheng, Mirjana Kessler, Udo Jeschke, et al.
Journal of Cancer Research and Clinical Oncology
|
September 6, 2019
EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancer
Bastian Czogalla, Christina Kuhn, Sabine Heublein, et al.
International Journal of Cancer
|
May 21, 2005
Immunotherapy of malignant ascites with trifunctional antibodies
Markus M Heiss, Michael A Ströhlein, Michael Jäger, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 118) with videos related to
Sort By:
Page
of 12
Clinical Chemistry and Laboratory Medicine
|
September 20, 2011
The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses
Miriam Lenhard, Petra Stieber, Linda Hertlein, et al.
Virchows Archiv : an International Journal of Pathology
|
February 9, 2019
Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma
Elisa Schmoeckel, Sophie Hofmann, Daniel Fromberger, et al.
International Journal of Molecular Sciences
|
June 20, 2019
Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients
Eileen Deuster, Doris Mayr, Anna Hester, et al.
Zentralblatt Fur Chirurgie
|
September 18, 2025
[The Free Functional Latissimus dorsi Flap for the Reconstruction of Complex Abdominal Wall Defects: Anatomy, Technique and Approach for Interdisciplinary Treatment]
Sinan Mert, Benedikt Fuchs, Alexander Burges, et al.
Brachytherapy
|
June 27, 2018
Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results
Franziska Walter, Cornelius Maihöfer, Lars Schüttrumpf, et al.
British Journal of Clinical Pharmacology
|
June 23, 2010
Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients
Peter Ruf, Michael Kluge, Michael Jäger, et al.
Clinical Chemistry
|
March 4, 2008
A new ELISA for use in a 3-ELISA system to assess concentrations of VEGF splice variants and VEGF(110) in ovarian cancer tumors
Johnny Gutierrez, Gottfried E Konecny, Kyu Hong, et al.
Cancers
|
January 25, 2025
Necroptosis-Related Gene Signature Predicts Prognosis in Patients with Advanced Ovarian Cancer
Mingjun Zheng, Mirjana Kessler, Udo Jeschke, et al.
Journal of Cancer Research and Clinical Oncology
|
September 6, 2019
EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancer
Bastian Czogalla, Christina Kuhn, Sabine Heublein, et al.
International Journal of Cancer
|
May 21, 2005
Immunotherapy of malignant ascites with trifunctional antibodies
Markus M Heiss, Michael A Ströhlein, Michael Jäger, et al.
Page
of 12